Back to Journals » Clinical Ophthalmology » Volume 18

Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study

Total article views   HTML views PDF downloads Totals
588 Dovepress* 588+ 54 642
Totals 588 54 642
*Since 24 June 2024

View citations on Google Scholar